[1] |
PARSONS A S, BURGER A, PAHWA A K. Clinical guideline highlights for the hospitalist: diagnosis and management of Clostridium difficile in adults[J]. J Hosp Med,2020,15(2):95-96. |
[2] |
ELLIOTT B, ANDROGA G O, KNIGHT D R, et al. Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology[J]. Infect Genet Evol,2017,49:1-11. doi: 10.1016/j.meegid.2016.12.018 |
[3] |
HE M, MIYAJIMA F, ROBERTS P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile[J]. Nat Genet,2013,45(1):109-113. doi: 10.1038/ng.2478 |
[4] |
MAGILL S S, EDWARDS J R, BAMBERG W, et al. Multistate point-prevalence survey of health care-associated infections[J]. N Engl J Med,2014,370(13):1198-1208. doi: 10.1056/NEJMoa1306801 |
[5] |
谢和宾, 曾鸿, 尹柯, 等. 我国住院腹泻患者艰难梭菌感染率的荟萃分析[J]. 中华医院感染学杂志, 2017, 27(5):961-964. |
[6] |
徐亚青, 邓敏. 难辨梭状芽胞杆菌医院感染的流行病学特征及感染控制现状分析[J]. 中华医院感染学杂志, 2013, 23(20):5073-5075. |
[7] |
BASSETTI M, VILLA G, PECORI D, et al. Epidemiology, diagnosis and treatment of Clostridium difficile infection[J]. Expert Rev Anti - Infect Ther,2012,10(12):1405-1423. doi: 10.1586/eri.12.135 |
[8] |
程敬伟, 刘文恩, 马小军, 等. 中国成人艰难梭菌感染诊断和治疗专家共识[J]. 协和医学杂志, 2017(Z1):131-138. |
[9] |
JOHNSON S, LOUIE TJ, GERDING DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials[J]. Clin Infect Dis,2014,59(3):345-354. doi: 10.1093/cid/ciu313 |
[10] |
MCDONALD L C, GERDING D N, JOHNSON S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)[J]. Clin Infect Dis,2018,66(7):987-994. doi: 10.1093/cid/ciy149 |
[11] |
HALLIDAY H L. Useless perinatal therapies[J]. Neonatology,2010,97(4):358-365. doi: 10.1159/000297765 |
[12] |
段涛. 妊娠期铁缺乏和缺铁性贫血诊治指南[J]. 中华围产医学杂志, 2014, 17(7):451-454. doi: 10.3760/cma.j.issn.1007-9408.2014.07.006 |
[13] |
BATES S M, GREER I A, MIDDELDORP S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th Ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest,2012,141(2 Suppl):e691S-e736S. |
[14] |
JAMES A, COMMITTEE ON PRACTICE BULLETINS—OBSTETRICS. Practice bulletin No. 123: thromboembolism in pregnancy[J]. Obstet Gynecol,2011,118(3):718-729. doi: 10.1097/AOG.0b013e3182310c4c |
[15] |
STEINBERG Z L, DOMINGUEZ-ISLAS C P, OTTO C M, et al. Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves[J]. J Am Coll Cardiol,2017,69(22):2681-2691. doi: 10.1016/j.jacc.2017.03.605 |